Remede System Approved for Central Sleep Apnea

Remede System Approved for Central Sleep Apnea

MONDAY, Oct. 9, 2017 (HealthDay News) — The Remede sleep system, an implanted device that treats central sleep apnea, has been approved by the U.S. Food and Drug Administration.

The new system, including a battery pack implanted in the chest, stimulates the phrenic nerve and monitors a patient’s lung function during sleep, the FDA said.

In clinical testing involving 141 individuals, the apnea hypopnea index was reduced by at least half among 51 percent of people who used the system. That compared with an 11 percent reduction among those who didn’t have the system implanted.

The most common adverse reactions included implant-site infection and swelling near the implant site. The system should not be implanted in people with an active infection or among people who require use of a magnetic resonance imaging machine, the FDA said.

The system is produced by Respicardia Inc., based in Minnetonka, Minnesota.

More Information

Health News Copyright © 2017 HealthDay. All rights reserved.

1 Comment

  1. How can I find out if I would be eligible for the remede system? I have been diagnosed w/ a slight case of sleep apnea, but have been put on the c-pap device which is very, very uncomfortable


Submit a Comment

Your email address will not be published. Required fields are marked *

20 − 3 =